In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient
- PMID: 1600599
- DOI: 10.1007/BF00686397
In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient
Abstract
The in vivo distribution of the antileukemic agent busulfan labeled with the positron-emitting radionuclide carbon 11 was investigated in cynomolgus monkeys and in a human patient using positron emission tomography. After i.v. injection of the radiotracer, its regional uptake was monitored for about 1 h in the monkey's body and, in a separate experiment, in the monkey's brain. The concentration of radioactivity in the liver, which showed the highest levels of all the organs scanned, increased throughout the experiment and was 9-fold that in the brain at the end of the experiment. [11C]-Busulfan rapidly crossed the blood-brain barrier. The radioactivity peaked in both the cortex and the white matter showing a ratio of 1.25, at 3 min but declined quickly to yield a ratio of approximately 1 after 30 min. In the human brain, radioactivity in the cerebellum, cortex, and white matter reached a maximum within 5 min showing a cortex:white matter ratio of 1.6. The activity in the cortex declined to yield a ratio of 1 within 30 min. Of the delivered dose, 20% penetrated into the brain.
Similar articles
-
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.Eur J Nucl Med. 1998 Apr;25(4):338-46. doi: 10.1007/s002590050230. Eur J Nucl Med. 1998. PMID: 9553162
-
Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo.J Neural Transm Park Dis Dement Sect. 1989;1(3):195-205. doi: 10.1007/BF02248669. J Neural Transm Park Dis Dement Sect. 1989. PMID: 2789067
-
Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.Nucl Med Biol. 2005 Jan;32(1):75-86. doi: 10.1016/j.nucmedbio.2004.07.001. Nucl Med Biol. 2005. PMID: 15691664
-
Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1520-8. doi: 10.1007/s00259-003-1307-x. Epub 2003 Sep 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 14579092
-
Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.J Neurol Sci. 2002 Nov 15;203-204:259-62. doi: 10.1016/s0022-510x(02)00301-5. J Neurol Sci. 2002. PMID: 12417394 Review.
Cited by
-
Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.Eur J Clin Pharmacol. 2012 Jun;68(6):923-35. doi: 10.1007/s00228-011-1209-y. Eur J Clin Pharmacol. 2012. PMID: 22286157
-
Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.J Nanobiotechnology. 2016 Dec 19;14(1):82. doi: 10.1186/s12951-016-0239-0. J Nanobiotechnology. 2016. PMID: 27993139 Free PMC article.
-
Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.J Vis Exp. 2015 Apr 1;(98):e52553. doi: 10.3791/52553. J Vis Exp. 2015. PMID: 25867947 Free PMC article.
-
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations.Br J Cancer. 1999 Feb;79(5-6):787-92. doi: 10.1038/sj.bjc.6690126. Br J Cancer. 1999. PMID: 10070870 Free PMC article.
-
Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.Cancer Chemother Pharmacol. 1993;33(3):181-6. doi: 10.1007/BF00686213. Cancer Chemother Pharmacol. 1993. PMID: 8269597
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources